Biocon names Peter Bains as Group CEO
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
The products will be manufactured at the company's facility in Bengaluru
The product is expected to start contributing meaningfully to the revenue from FY25
The hospital hosted a two-day event with top internal and external faculty and medical experts
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Subscribe To Our Newsletter & Stay Updated